Marshall Wace North America L.P. Buys New Shares in Rosetta Stone Inc (NYSE:RST)

Marshall Wace North America L.P. bought a new position in Rosetta Stone Inc (NYSE:RST) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 19,675 shares of the software maker’s stock, valued at approximately $430,000. Marshall Wace North America L.P. owned approximately 0.08% of Rosetta Stone as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. Marshall Wace LLP bought a new position in Rosetta Stone during the 1st quarter valued at approximately $34,000. Quantamental Technologies LLC bought a new position in Rosetta Stone during the 1st quarter valued at approximately $46,000. Great West Life Assurance Co. Can bought a new position in Rosetta Stone during the 4th quarter valued at approximately $54,000. Legal & General Group Plc increased its position in Rosetta Stone by 34.8% during the 4th quarter. Legal & General Group Plc now owns 3,936 shares of the software maker’s stock valued at $65,000 after buying an additional 1,016 shares in the last quarter. Finally, Neuburgh Advisers LLC bought a new position in Rosetta Stone during the 4th quarter valued at approximately $76,000. 82.44% of the stock is owned by hedge funds and other institutional investors.

NYSE RST traded down $0.16 on Thursday, hitting $23.63. 63,038 shares of the company traded hands, compared to its average volume of 206,119. The firm has a market cap of $569.78 million, a P/E ratio of -24.87 and a beta of 0.23. The business has a 50 day simple moving average of $23.46. Rosetta Stone Inc has a 52-week low of $14.14 and a 52-week high of $26.88.

Rosetta Stone (NYSE:RST) last released its earnings results on Tuesday, May 7th. The software maker reported ($0.02) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.24) by $0.22. The company had revenue of $44.61 million for the quarter, compared to analysts’ expectations of $43.50 million. Research analysts forecast that Rosetta Stone Inc will post -0.6 EPS for the current fiscal year.

A number of research analysts recently weighed in on RST shares. ValuEngine raised Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, April 1st. Lake Street Capital reduced their price objective on Farmer Bros from $36.00 to $26.00 and set a “buy” rating for the company in a research report on Wednesday, May 8th. Zacks Investment Research downgraded Hess Midstream Partners from a “hold” rating to a “sell” rating in a research note on Tuesday, May 14th. Finally, Barrington Research raised their price target on Franklin Covey from $34.00 to $40.00 and gave the stock an “outperform” rating in a research note on Friday, June 28th. Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $28.50.

In other Rosetta Stone news, insider Nicholas C. Gaehde sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, July 10th. The stock was sold at an average price of $22.69, for a total transaction of $56,725.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director David Nierenberg sold 45,127 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $25.60, for a total value of $1,155,251.20. The disclosure for this sale can be found here. Insiders have sold 262,355 shares of company stock valued at $6,561,632 in the last 90 days. Company insiders own 13.50% of the company’s stock.

About Rosetta Stone

Rosetta Stone Inc, together with its subsidiaries, provides technology-based learning products in the United States and internationally. It operates through three segments: Literacy, E&E Language, and Consumer Language. The company develops, markets, and supports a suite of language-learning, literacy, and brain fitness solutions consisting of Web-based software subscriptions, perpetual software products, online and professional services, audio practice products, and mobile applications.

Further Reading: What are some reasons analysts would give stocks a buy rating?

Institutional Ownership by Quarter for Rosetta Stone (NYSE:RST)

Receive News & Ratings for Rosetta Stone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Stone and related companies with MarketBeat.com's FREE daily email newsletter.